Search - tctmd.com

Displaying 701 - 720 of 795

Sort: Relevancy | Date

Presentation TCT 2012

Progress with Drug-Eluting Magnesium Resorbing Stents (BIOTRONIK): DREAMS 2-Year Results

Presenter: Michael Haude

October 23, 2012

Presentation TCT 2012

After CTO Recanalization, What Is the Role of Drug-Eluting Devices, Covered Stents, Etc?

Presenter: Thomas Zeller

October 23, 2012

Presentation TCT 2012

What Can Advanced Stent Imaging Tell Us About In-Stent Restenosis, Plaque Prolapse, and Design of Future Stents?

Presenter: Mark Wholey

October 22, 2012

Presentation TCT 2012

Stents and Vascular Healing: New Concepts

Presenter: Hyo-Soo Kim

October 22, 2012

Presentation TCT 2012

Rationale for Dedicated Bifurcation Stents, and Propsed Classification

Presenter: John Ormiston

October 22, 2012

Presentation TCT 2012

Randomized Trials Don't Reflect the Real World: Two Stents Should Be Used 50% of Bifurcation Lesions or More!

Presenter: Antonio Colombo

October 22, 2012

Presentation TCT 2012

Exciting Cardiovascular Device Innovation from Europe: From Balloons to Stents to Closure Devices and More

Presenter: Alessandro Bortone

October 22, 2012

Presentation TCT 2012

Everolimus-Eluting Stents: SPIRIT and PLATINUM Update

Presenter: Gregg Stone

October 22, 2012

Presentation TCT 2012

Dedicated Bifurcation Stents: Tryton Program Update

Presenter: Martin Leon

October 22, 2012

Presentation TCT 2012

Dedicated Bifurcation Stents: Minvasys Nile Program Update

Presenter: Roxana Mehran

October 22, 2012

Presentation TCT 2012

Dedicated Bifurcation Stents: Cappella Program Update

Presenter: Fernando Cura

October 22, 2012

Presentation TCT 2012

Dedicated Bifurcation Stents: Biosensors Program Update

Presenter: Stefan Verheye

October 22, 2012

Presentation TCT 2012

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Pro!

Presenter: Gary Ansel

October 22, 2012

Presentation TCT 2012

Bioabsorbable Stents

Presenter: Hector Garcia-Garcia

October 22, 2012

Presentation TCT 2012

Are the Outcomes of Left Main Stenting Improving with Second Generation Stents? Results of PRECOMBAT-2

Presenter: Young-Hak Kim

October 22, 2012

Presentation TCT 2012

When Are Two Stents Not Needed for the Distal Left Main Bifurcation?

Presenter: David Hildick-Smith

October 22, 2012

Presentation TCT 2012

The Data Are Clear: The Careful Operator Should Implant Two Stents in No More Than 10% of Bifurcation Lesions!

Presenter: Liliana Grinfeld

October 22, 2012

Presentation TCT 2012

J-DESSERT: A Prospective, Randomized Trial of Paclitaxel-Eluting vs. Sirolimus-Eluting Stents in Patients with and without Diabetes

Presenter: Masato Nakamura

October 22, 2012

Presentation TCT 2012

Final Data on the ICARUS Trial of Covered Stents for Obstructive Iliac Disease

Presenter: John Laird Jr

October 22, 2012

Presentation TCT 2012

Dedicated Bifurcation Stents: Xience SBA Program Update

Presenter: David Rizik

October 22, 2012

Advertisement

Progress with Drug-Eluting Magnesium Resorbing Stents (BIOTRONIK): DREAMS 2-Year Results

After CTO Recanalization, What Is the Role of Drug-Eluting Devices, Covered Stents, Etc?

What Can Advanced Stent Imaging Tell Us About In-Stent Restenosis, Plaque Prolapse, and Design of Future Stents?

Stents and Vascular Healing: New Concepts

Rationale for Dedicated Bifurcation Stents, and Propsed Classification

Randomized Trials Don't Reflect the Real World: Two Stents Should Be Used 50% of Bifurcation Lesions or More!

Exciting Cardiovascular Device Innovation from Europe: From Balloons to Stents to Closure Devices and More

Everolimus-Eluting Stents: SPIRIT and PLATINUM Update

Dedicated Bifurcation Stents: Tryton Program Update

Dedicated Bifurcation Stents: Minvasys Nile Program Update

Dedicated Bifurcation Stents: Cappella Program Update

Dedicated Bifurcation Stents: Biosensors Program Update

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Pro!

Bioabsorbable Stents

Are the Outcomes of Left Main Stenting Improving with Second Generation Stents? Results of PRECOMBAT-2

When Are Two Stents Not Needed for the Distal Left Main Bifurcation?

The Data Are Clear: The Careful Operator Should Implant Two Stents in No More Than 10% of Bifurcation Lesions!

J-DESSERT: A Prospective, Randomized Trial of Paclitaxel-Eluting vs. Sirolimus-Eluting Stents in Patients with and without Diabetes

Final Data on the ICARUS Trial of Covered Stents for Obstructive Iliac Disease

Dedicated Bifurcation Stents: Xience SBA Program Update

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content